Literature DB >> 7486562

V-gene repertoire and hypermutation of rheumatoid factors produced in rheumatoid synovial inflammation and immunized healthy donors.

K M Thompson1, M Børretzen, I Randen, O Førre, J B Natvig.   

Abstract

We have compared RF from normal, immunized donors and RF derived from the synovial tissues of RA patients. We have found a difference in the preferential use of VL and VH gene families. In both conditions, RFs were found to have accumulated somatic mutations. However, there was a striking difference in the patterns of mutation. RFs from normals were characterized by a very low R:S ratio in the CDR1+2, considerably lower than seen among the RARFs. In addition, there was little increase in affinity with increasing numbers of mutations in a group of clonally related RFs from an immunized normal. This contrasts with RF from RA, where there is evidence of both affinity maturation and class switching. Together these data suggest that in healthy persons there is a controlling mechanism to limit the affinity of RF autoantibodies, and that this is lost in RA. The higher affinity of the RA-derived RF may be of significance in the pathology of the disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7486562     DOI: 10.1111/j.1749-6632.1995.tb55861.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  Rheumatoid factor isotype switch and somatic mutation variants within rheumatoid arthritis synovium.

Authors:  D G Williams; S P Moyes; R A Mageed
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

2.  Age-related accumulation of Ig V(H) gene somatic mutations in peripheral B cells from aged humans.

Authors:  Y Chong; H Ikematsu; K Yamaji; M Nishimura; S Kashiwagi; J Hayashi
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

3.  Human IgG Fc-binding phage antibodies constructed from synovial fluid CD38+ B cells of patients with rheumatoid arthritis show the imprints of an antigen-dependent process of somatic hypermutation and clonal selection.

Authors:  W J E Van Esch; C C Reparon-Schuijt; H J Hamstra; C Van Kooten; T Logtenberg; F C Breedveld; C L Verweij
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

4.  New Relationships for Old Autoantibodies in Rheumatoid Arthritis.

Authors:  Miriam A Shelef
Journal:  Arthritis Rheumatol       Date:  2019-08-01       Impact factor: 15.483

5.  B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis.

Authors:  Joseph M Tuscano; Jacob Sands
Journal:  Biologics       Date:  2009-07-13

6.  Rituximab and its potential for the treatment of rheumatoid arthritis.

Authors:  Adam Bryant; John Moore
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

Review 7.  Tertiary Lymphoid Structures: Autoimmunity Goes Local.

Authors:  Elena Pipi; Saba Nayar; David H Gardner; Serena Colafrancesco; Charlotte Smith; Francesca Barone
Journal:  Front Immunol       Date:  2018-09-12       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.